title: Engraftment of bone marrow cells into normal unprepared hosts: effects of 5-fluorouracil and cell cycle status.
abstract: Bone marrow from animals treated with 5-fluorouracil (5FU) competes equally with normal marrow when assessed in vivo in an irradiated mouse, but shows markedly defective engraftment when transplanted into noncytoablated hosts. Using Southern Blot analysis and a Y-chromosome specific probe, we determined the level of engraftment of male donor cells in the bone marrow, spleen, and thymus of unprepared female hosts. We have confirmed the defective engraftment of marrow harvested 6 days after 5FU (FU-6) and transplanted into unprepared hosts and shown that this defect is transient; by 35 days after 5FU (FU-35), engraftment has returned to levels seen with normal marrow. FU-6 marrow represents an actively cycling population of stem cells, and we hypothesize that the cycle status of the stem cell may relate to its capacity to engraft in the nonirradiated host. Accordingly, we have evaluated the cycle status of engrafting normal and FU-6 marrow into normal hosts using an in vivo hydroxyurea technique. We have shown that those cells engrafting from normal marrow and over 70% of the cells engrafting from FU-6 marrow were quiescent, demonstrating no killing with hydroxyurea. We have also used fluorescent in situ hybridization (FISH) analysis with a Y-chromosome probe and demonstrated that normal and post-5FU engraftment patterns in peripheral blood were similar to those seen in bone marrow, spleen, and thymus. Altogether these data indicate that cells engrafting in normal, unprepared hosts are dormant, and the defect that occurs after 5FU is concomitant with the induction of these cells to transit the cell cycle.
authors.affiliation: Cancer Center, University of Massachusetts Medical Center, Worcester, USA.
authors.forename: H S
authors.initials: HS
authors.lastname: Ramshaw
authors.forename: S S
authors.initials: SS
authors.lastname: Rao
authors.forename: R B
authors.initials: RB
authors.lastname: Crittenden
authors.forename: S O
authors.initials: SO
authors.lastname: Peters
authors.forename: H U
authors.initials: HU
authors.lastname: Weier
authors.forename: P J
authors.initials: PJ
authors.lastname: Quesenberry
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000379:methods*; D002453:Cell Cycle; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology*; D006918:Hydroxyurea / Q000494:pharmacology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C
chemical_list: D005472:Fluorouracil; D006918:Hydroxyurea